Upcoming Clinical Trial Presentation - Stocks of the Day

Stocks of the Day

Sign In / Sign Up

Latest News
Stock Screener
AI Signals
News Archive
Membership
About
- About
- FAQ
- Blog
- Contact Us

Home
Latest News
Stock Screener
AI Signals
News Archive
Membership
About
- About
- FAQ
- Blog
- Contact Us

Register Free
Sign in

Search mobile

Topic :

Upcoming Clinical Trial Presentation

NASDAQ, SRDX

#Financial Report Scheduled #Upcoming Clinical Trial Presentation

Surmodics to Report First Quarter of Fiscal 2023 Financial Results on February 6

January 26, 2023
08:30

EST

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that first quarter of fiscal year 2023 financial results will be released after the market closes on Monday, February 6. Management will host a live

No Comments

NASDAQ, NAUT

#Financial Report Scheduled #Upcoming Clinical Trial Presentation

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

January 26, 2023
08:00

EST

SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year of 2022 before market open on Thursday, February 23, 2023. The company’s management

No Comments

AGEN, NASDAQ

#Cancer #Investor Conference #Upcoming Clinical Trial Presentation

Agenus to Participate in February Investor Conferences

January 26, 2023
07:30

EST

LEXINGTON, Mass., Jan. 26, 2023 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immunological agents targeting cancer and infectious disease, today announced that Dr. Garo Armen, Chairman and CEO, and Dr. Steven O’Day, Chief Medical Officer, will participate in the following upcoming investor conferences:

No Comments

MDNA, NASDAQ

#Financial Report Scheduled #Upcoming Clinical Trial Presentation

Medicenna to Announce Third Quarter Fiscal 2023 Financial Results and Operational Highlights on Tuesday, February 7, 2023

January 26, 2023
07:00

EST

TORONTO and HOUSTON, Jan. 26, 2023 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immuno-oncology company, today announced that it will host a conference call and live webcast on February 7, 2023 at 8:30 AM ET to report its third

No Comments

IQV, NYSE

#Financial Report Scheduled #Upcoming Clinical Trial Presentation

IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023

January 25, 2023
16:15

EST

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) will announce its fourth-quarter and full-year 2022 financial results before the market opens on Friday, February 10, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day.

No Comments

INNV, NASDAQ

#Financial Report Scheduled #Upcoming Clinical Trial Presentation

InnovAge to Announce Fiscal Second Quarter 2023 Financial Results and Host Conference Call Tuesday, February 7, 2023

January 24, 2023
16:05

EST

DENVER, Jan. 24, 2023 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV) will release its 2023 fiscal second quarter financial results on Tuesday, February 7, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. Conference Call

No Comments

ATRC, NASDAQ

#Financial Report Scheduled #Upcoming Clinical Trial Presentation

AtriCure to Announce Fourth Quarter and Full Year 2022 Financial Results and Participate in 2023 BTIG Medical Technology Conference

January 24, 2023
08:00

EST

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its fourth quarter and full year 2022 financial results on Tuesday, February 21, 2023. AtriCure will

No Comments

CFMS, NASDAQ

#Financial Report Scheduled #Upcoming Clinical Trial Presentation

Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022

January 23, 2023
16:30

EST

BILLERICA, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the fourth quarter and full-year ended December 31, 2022, after the market closes on Wednesday,

No Comments

NASDAQ, UNCY

#kidney #Trending News #Upcoming Clinical Trial Presentation

Unicycive Announces Acceptance of Three Abstracts for Presentation at the National Kidney Foundation’s Spring Clinical Meetings

January 23, 2023
07:00

EST

LOS ALTOS, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that three abstracts have been accepted for presentation at the National Kidney Foundation’s (NFK) upcoming Spring Clinical Meetings taking place in Austin, Texas

No Comments

LVTX, NASDAQ

#Cancer #Upcoming Clinical Trial Presentation

LAVA Therapeutics to Present LAVA-1207 Clinical Data at the 2023 ASCO GU Symposium

January 23, 2023
07:00

EST

UTRECHT, The Netherlands and PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq: LVTX), an immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma-delta T cell engagers to transform the treatment of cancer, today announced that clinical data from a Phase 1/2a study in

No Comments

< Page1 Page2 Page3 … Page83 >

Trending News

Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

01/29/2023

California American Water Applies for Water Resources Sustainability Plan

01/27/2023

Helbiz Provides Transparency on Filed Proxy Statement

01/27/2023

CNEY Announces Proposed Underwritten Public Offering of Securities

01/27/2023

CNEY Reports Its Audited Financial Results for Fiscal Year 2022

01/27/2023

Most read news

STEER Announces a Proposed Transaction for an $18 Million Direct Investment Involving its Digital Restaurant Supply Business (B2B Marketplace)

01/23/2023

Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress

01/23/2023

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Silvergate Capital Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SI

01/23/2023

© 2022 stocksoftheday.

Stocks of the Day does not provide investment advice. All rights reserved.

Tools

Predictions
Stock Screener
News Archive
News Feed
News Tags
Tickers
Trending Tickers
News Sentiments
Holidays & Trading Hours

Learn

FAQ
Guides
Infographics
Affiliate Program FAQ

Account

Sign In
Register
Email Preferences
Membership Option

Company

About
Contact Us
Careers
Blog
Privacy Policy
Terms of Use
Sitemap

Partnerships

Affiliate Program
Partnerships

Create account

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

First Name

Last Name

Email

Password

I agree with the Terms of Use and Privacy Policy.

Already have an account?

Sign In

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

Email

Password

Remember me

Lost your password?

Not registered yet?

Create a free account

Sign In

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

Email

Password

Remember me

Lost your password?

Not registered yet?

Create a free account